2seventy bio Inc (TSVT)
4.38
-0.06
(-1.24%)
USD |
NASDAQ |
May 10, 16:00
4.39
+0.01
(+0.23%)
After-Hours: 20:00
2seventy bio Free Cash Flow: -180.72M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -180.72M |
| September 30, 2023 | -174.78M |
| June 30, 2023 | -224.56M |
| March 31, 2023 | -237.05M |
| December 31, 2022 | -258.95M |
| Date | Value |
|---|---|
| September 30, 2022 | -258.46M |
| June 30, 2022 | -236.40M |
| March 31, 2022 | -232.40M |
| December 31, 2021 | -226.43M |
Free Cash Flow Range, Past 5 Years
-258.95M
Minimum
Dec 2022
-174.78M
Maximum
Sep 2023
-225.53M
Average
-232.40M
Median
Mar 2022
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 12.51B |
| Johnson & Johnson | 18.23B |
| Macrogenics Inc | -79.97M |
| Akebia Therapeutics Inc | -23.38M |
| Tango Therapeutics Inc | -119.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -63.60M |
| Cash from Investing (Quarterly) | 47.89M |
| Cash from Financing (Quarterly) | 0.253M |
| Free Cash Flow Per Share (Quarterly) | -1.258 |
| Free Cash Flow to Equity (Quarterly) | -64.67M |
| Free Cash Flow to Firm (Quarterly) | -64.67M |
| Free Cash Flow Yield | -83.77% |